#pharma #ipo
πΊπΈ #ATEA PHARMACEUTICALS
β Stage: IPO
β Type: Equity
β Invest: $253M
β Valuation: $2 000M
β Revenue (1H2020): $0M
β EBIT (1H2020): $-14M
β Net Income (1H2020): $-14M
β Net Debt (1H2020): $0M
β Total Addressable Market (TAM): $40 000M
β Oversubscribed: Medium
(source: IPO Boutique)
β Analyst rating: Neutral
(source: IPO Boutique)
β Upside: 36%
@freenewspaper
πΊπΈ #ATEA PHARMACEUTICALS
β Stage: IPO
β Type: Equity
β Invest: $253M
β Valuation: $2 000M
β Revenue (1H2020): $0M
β EBIT (1H2020): $-14M
β Net Income (1H2020): $-14M
β Net Debt (1H2020): $0M
β Total Addressable Market (TAM): $40 000M
β Oversubscribed: Medium
(source: IPO Boutique)
β Analyst rating: Neutral
(source: IPO Boutique)
β Upside: 36%
@freenewspaper
π#cars #retail #energy #banks #pharma #tech #travel #marketsize
INDUSTRY OUTLOOK 2023
@freenewspaper
INDUSTRY OUTLOOK 2023
@freenewspaper
π#ai #datacenters #electricity #cybersecurity #population #pharma #wellness #marketsize #forecast
THE WORLD IN 2030.
βββββββββ
π *only for Scorpi18 subscribers on the 'Forever' tariff plan.
THE WORLD IN 2030.
βββββββββ
Please open Telegram to view this post
VIEW IN TELEGRAM
Please open Telegram to view this post
VIEW IN TELEGRAM
This media is not supported in your browser
VIEW IN TELEGRAM
πΊπΈ#healthcare #pharma
EYE ON THE MARKET - US HEALTHCARE.
ββββββββββββββ
π *only for Scorpi18 subscribers on the 'Forever' tariff plan.
EYE ON THE MARKET - US HEALTHCARE.
ββββββββββββββ
Please open Telegram to view this post
VIEW IN TELEGRAM
Please open Telegram to view this post
VIEW IN TELEGRAM